BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia

The molecular basis of human leukemia is heterogeneous. Cytogenetic findings are increasingly associated with molecular abnormalities, some of which are being understood at the functional level. Specific therapies can be developed based on such knowledge. To search for new genes in the acute leukemias, we performed a representational difference analysis. We describe a human gene in chromosome 8q22.3, BAALC (brain and acute leukemia, cytoplasmic), that is highly conserved among mammals but evidently absent from lower organisms. We characterized BAALC on the genomic level and investigated its expression pattern in human and mouse, as well as its complex splicing behavior. In vitro studies of the protein showing its subcellular localization suggest a function in the cytoskeleton network. Two isoforms are specifically expressed in neuroectoderm-derived tissues, but not in tumors or cancer cell lines of nonneural tissue origin. We show that blasts from a subset of patients with acute leukemia greatly overexpress eight different BAALC transcripts, resulting in five protein isoforms. Among patients with acute myeloid leukemia, those overexpressing BAALC show distinctly poor prognosis, pointing to a key role of the BAALC products in leukemia. Our data suggest that BAALC is a gene implicated in both neuroectodermal and hematopoietic cell functions.

[1]  Lucia Altucci,et al.  The promise of retinoids to fight against cancer , 2001, Nature Reviews Cancer.

[2]  J. Licht Targeting aberrant transcriptional repression in leukemia: a therapeutic reality? , 2001, Journal of Clinical Investigation.

[3]  P. D. de Jong,et al.  A bacterial artificial chromosome library for sequencing the complete human genome. , 2001, Genome research.

[4]  C. Bloomfield,et al.  Clinical importance of cytogenetics in acute myeloid leukaemia. , 2001, Best practice & research. Clinical haematology.

[5]  Irving L. Weissman,et al.  A Genetic Analysis of Neural Progenitor Differentiation , 2001, Neuron.

[6]  J. Eppig,et al.  Cross-referencing radiation hybrid data to the recombination map: lessons from mouse chromosome 18. , 2000, Genomics.

[7]  C. Bloomfield,et al.  Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. , 1999, Blood.

[8]  C. Bloomfield,et al.  Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  M. Caligiuri,et al.  Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. , 1998, Cancer research.

[10]  A T Look,et al.  Oncogenic transcription factors in the human acute leukemias. , 1997, Science.

[11]  Michael J. O'Neill,et al.  Isolation of rare transcripts by representational difference analysis , 1997, Nucleic Acids Res..

[12]  Caligiuri Ma,et al.  Molecular biology of acute myeloid leukemia. , 1997 .

[13]  M. Caligiuri,et al.  Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. , 1996, Cancer research.

[14]  E. Roeder,et al.  Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. , 1995, Genomics.

[15]  M. Caligiuri,et al.  ALL-1 partial duplication in acute leukemia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M Hubank,et al.  Identifying differences in mRNA expression by representational difference analysis of cDNA. , 1994, Nucleic acids research.

[17]  H. Sambrook Molecular cloning : a laboratory manual. Cold Spring Harbor, NY , 1989 .

[18]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .